175 related articles for article (PubMed ID: 27852542)
1. Factors associated with elevated serum chromogranin A levels in patients with autoimmune gastritis.
Kalkan Ç; Karakaya F; Soykan İ
Turk J Gastroenterol; 2016 Nov; 27(6):515-520. PubMed ID: 27852542
[TBL] [Abstract][Full Text] [Related]
2. Chromogranin A as a useful neuroendocrine marker in patients with autoimmune Addison's disease.
El Ali Z; Fichna M; Piniewska J; Kosowicz J; Grzymisławski M
J Endocrinol Invest; 2010 Mar; 33(3):186-91. PubMed ID: 19794299
[TBL] [Abstract][Full Text] [Related]
3. Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin-like cell hyperplasia and autoimmune gastritis.
Herold Z; Herold M; Nagy P; Patocs A; Doleschall M; Somogyi A
J Diabetes Investig; 2020 Jul; 11(4):865-873. PubMed ID: 31883432
[TBL] [Abstract][Full Text] [Related]
4. [Study on histogenesis of enterochromaffin-like carcinoid in autoimmune atrophic gastritis associated with pernicious anemia].
Macukanović-Golubović L; Katić V; Rancić G; Milenović M; Marjanović G; Golubović Z
Vojnosanit Pregl; 2007 Aug; 64(8):543-8. PubMed ID: 17874722
[TBL] [Abstract][Full Text] [Related]
5. Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids.
Peracchi M; Gebbia C; Basilisco G; Quatrini M; Tarantino C; Vescarelli C; Massironi S; Conte D
Eur J Endocrinol; 2005 Mar; 152(3):443-8. PubMed ID: 15757862
[TBL] [Abstract][Full Text] [Related]
6. Are patients with autoimmune thyroid disease and autoimmune gastritis at risk of gastric neuroendocrine neoplasms type 1?
Alexandraki KI; Nikolaou A; Thomas D; Syriou V; Korkolopoulou P; Sougioultzis S; Kaltsas G
Clin Endocrinol (Oxf); 2014 May; 80(5):685-90. PubMed ID: 24118101
[TBL] [Abstract][Full Text] [Related]
7. [Development of silent gastric carcinoid in a type 1 diabetic patient with primer hypothyreosis].
Somogyi A; Ruzicska E; Varga T; Rácz K; Nagy G
Orv Hetil; 2007 Sep; 148(35):1667-71. PubMed ID: 17720674
[TBL] [Abstract][Full Text] [Related]
8. Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis.
Borch K; Stridsberg M; Burman P; Rehfeld JF
Scand J Gastroenterol; 1997 Mar; 32(3):198-202. PubMed ID: 9085454
[TBL] [Abstract][Full Text] [Related]
9. Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy.
Sanduleanu S; De Bruïne A; Stridsberg M; Jonkers D; Biemond I; Hameeteman W; Lundqvist G; Stockbrügger RW
Eur J Clin Invest; 2001 Sep; 31(9):802-11. PubMed ID: 11589723
[TBL] [Abstract][Full Text] [Related]
10. Polyautoimmunity in autoimmune gastritis.
Kalkan Ç; Soykan I
Eur J Intern Med; 2016 Jun; 31():79-83. PubMed ID: 27085391
[TBL] [Abstract][Full Text] [Related]
11. A meal test improves the specificity of chromogranin A as a marker of neuroendocrine neoplasia.
Jianu CS; Fossmark R; Syversen U; Hauso Ø; Waldum HL
Tumour Biol; 2010 Oct; 31(5):373-80. PubMed ID: 20480408
[TBL] [Abstract][Full Text] [Related]
12. Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids.
Jianu CS; Fossmark R; Syversen U; Hauso Ø; Fykse V; Waldum HL
Scand J Gastroenterol; 2011 Apr; 46(4):456-63. PubMed ID: 21133821
[TBL] [Abstract][Full Text] [Related]
13. Clinical profiles, endoscopic and laboratory features and associated factors in patients with autoimmune gastritis.
Soykan I; Yakut M; Keskin O; Bektaş M
Digestion; 2012; 86(1):20-6. PubMed ID: 22710370
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune gastritis presenting as iron deficiency anemia in childhood.
Gonçalves C; Oliveira ME; Palha AM; Ferrão A; Morais A; Lopes AI
World J Gastroenterol; 2014 Nov; 20(42):15780-6. PubMed ID: 25400463
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune gastritis. A clinicopathologic study of 25 cases.
Chlumská A; Boudová L; Benes Z; Zámecník M
Cesk Patol; 2005 Oct; 41(4):137-42. PubMed ID: 16382988
[TBL] [Abstract][Full Text] [Related]
16. Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids.
Azzoni C; Doglioni C; Viale G; Delle Fave G; De Boni M; Caruana P; Ferraro G; Bordi C
Am J Surg Pathol; 1996 Apr; 20(4):433-41. PubMed ID: 8604810
[TBL] [Abstract][Full Text] [Related]
17. Hypergastrinemia and gastric enterochromaffin-like cells.
Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine tumor markers and enterochromaffin-like cell hyper/dysplasia in type 1 diabetes.
De Block CE; Colpin G; Thielemans K; Coopmans W; Bogers JJ; Pelckmans PA; Van Marck EA; Van Hoof V; Martin M; De Leeuw IH; Bouillon R; Van Gaal LF
Diabetes Care; 2004 Jun; 27(6):1387-93. PubMed ID: 15161793
[TBL] [Abstract][Full Text] [Related]
19. Histologic changes in type A chronic atrophic gastritis indicating increased risk of neuroendocrine tumor development: the predictive role of dysplastic and severely hyperplastic enterochromaffin-like cell lesions.
Vanoli A; La Rosa S; Luinetti O; Klersy C; Manca R; Alvisi C; Rossi S; Trespi E; Zangrandi A; Sessa F; Capella C; Solcia E
Hum Pathol; 2013 Sep; 44(9):1827-37. PubMed ID: 23642738
[TBL] [Abstract][Full Text] [Related]
20. Oxyntic gastric atrophy in Helicobacter pylori gastritis is distinct from autoimmune gastritis.
Venerito M; Varbanova M; Röhl FW; Reinhold D; Frauenschläger K; Jechorek D; Weigt J; Link A; Malfertheiner P
J Clin Pathol; 2016 Aug; 69(8):677-85. PubMed ID: 26729016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
